Tag Archives: ALL ORDINARIES

Xero still going strong

Recently, Xero Ltd.’s non-executive director Craig Winkler has reduced his shareholding to 10.5% (from 12.7%) to fund his private charitable trust. Winkler is a Director of Givia, the trustee for a private charitable trust and remains Xero’s second largest individual shareholder (via Givia) after Xero’s CEO, Rod Drury. Further, Winkler has informed Xero that he will seek to distribute 100%

Read more

One small cap wine company to buy – Australian Vintage Ltd.

Australian Vintage (ASX: AVG) has reported that it crushed 93,000 tons of grapes from the 2017 vintage compared to 99,000 tons last year, decreased by 6,000 tons compared to last year due mainly to a reduction in volumes processed for external customers. Yields from owned and leased vineyards are marginally above expectation and in line with last year. The 2017

Read more

During Q1FY17 (ending March 31, 2017) Freelancer Ltd reported a 20% yoy growth in cash receipts at $12.5 million on a rolling 12-month basis, with strong positive operating cashflow of $2.1 million.

During Q1FY17 (ending March 31, 2017) Freelancer Ltd reported a 20% yoy growth in cash receipts at $12.5 million on a rolling 12-month basis, with strong positive operating cashflow of $2.1 million. Q12017 witnessed a strong bounce in accepted projects as issues in the core desktop project funnel were corrected in mid-January 2017, while projects posted on mobile reported an

Read more

Two Australian technology stocks to buy – Freelancer Ltd and iSentia Group Ltd

During Q1FY17 (ending March 31, 2017) Freelancer Ltd reported a 20% yoy growth in cash receipts at $12.5 million on a rolling 12-month basis, with strong positive operating cashflow of $2.1 million. Q12017 witnessed a strong bounce in accepted projects as issues in the core desktop project funnel were corrected in mid-January 2017, while projects posted on mobile reported an

Read more

Are annual reports of a company useful?

Annual reports are the primary source of data about the company’s financial position, shareholders, strategy discussion, Market opportunity and their initiatives over their upcoming products or service launches. While some of them argue that annual reports of the companies might not be enough to understand the company’s investment thesis, we believe that Annual reports data would give enough information for

Read more

Creso Pharma Limited Pipeline of launches

Pipeline of launches: Creso Pharma Limited (ASX: CPH) reported that they are on track to launch their CannaQix human health nutraceutical product in anxiety and stress segment by first quarter or second quarter of 2018. They are also aiming and line extensions in bone metabolism by second quarter of 2019. The products use proprietary Swiss delivery technologies which would boost

Read more

Stemcell United Ltd Exploring options for Asia market

Exploring options for Asia market: Stemcell United Ltd (ASX: SCU) reported their signing of a Letter Agreement with iCAN Israel-Cannabis to negotiate and execute a mutually agreeable licensing and services agreement. ICAN would offer services to the group with respect to their business operations in Asia. Moreover, an investment agreement would be made with the group for over 5% to

Read more
« Older Entries